Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder

Journal of Clinical Psychopharmacology

Volumn 18, Issue 6 SUPPL. 2, 1998, Pages

  Gelder, Michael G ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE;

AGORAPHOBIA; BEHAVIOR THERAPY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE COST; HUMAN; PANIC; PRIORITY JOURNAL;

EID: 0031731655     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199812001-00002     Document Type: Conference Paper

References (13)

1. Munby M, Johnston DW. Agoraphobia:, the long-term follow-up of behavioural treatment. Br J Psychiatry 1980;137:418-27.
2. Goddard AW, Woods SW, Charney DS. A critical review of the role of norepinephrine in panic disorder: focus on its interaction with serotonin. In: Westenberg HGM, Den Boer JA, Murphy DL, eds. Advances in the neurobiology of anxiety disorders. New York: John Wiley, 1996:107-37.
3. Den Boer JA, Westenberg HGM. Involvement of serotonin receptor subtypes in panic disorder: a critical appraisal of the evidence. In: Westenberg HGM, Den Boer JA, Murphy DL, eds. Advances in the neurobiology of anxiety disorders. New York: John Wiley, 1996:139-72.
4. Clark DM. Panic disorder and social phobia. In: Clark DM, Fairburn CG, eds. Science and practice of cognitive behavior therapy. New York: Oxford University Press, 1997:121-53.
5. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Anastasiades P, Gelder M. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994;164:759-69.
6. Andrews G, Crino R, Hunt C, Lampe L, Page A. The treatment of anxiety disorders: clinician's guide and patient manuals. Cambridge, UK: Cambridge University Press, 1994;37-42.
7. Clum GA. Psychological interventions vs. drugs in the treatment of panic. Behav Ther 1989;20:429-57.
8. Marks IM, Swinson RP, Ba[cedil]so[icirc]glu M, Kuch K, Noshirvani H, O'Sullivan G, Lelliott PT, Kirby M, McNamee G, Sengun S, Wickwire K. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto. Br J Psychiatry 1993;162:776-87.
9. Tyrer P, Murphy S, Oates G, Kingdon D. Psychological treatment for benzodiazepine dependence. Lancet 1985;1:1042-3.
10. Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 1993;150:1485-90.
11. Black DW, Wesner R, Bowers W, Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:44-50.
12. Salkovskis PM, Clark DM, Hackmann A, Wells A, Gelder MG. An experimental investigation of the role of safety behaviours in the maintenance of panic disorder with agoraphobia. J Abnorm Psychol, in press.
13. Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M. A controlled trial of brief cognitive therapy for panic disorder. J Consult Clin Psychol, in press.